Literature DB >> 23486467

The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.

Keigo Nishii1, Chiaki Nakaseko, Meizi Jiang, Naomi Shimizu, Masahiro Takeuchi, Wolfgang J Schneider, Hideaki Bujo.   

Abstract

A key property of hematopoietic stem and progenitor cells (HSPCs) regarding differentiation from the self-renewing quiescent to the proliferating stage is their adhesion to the bone marrow (BM) niche. An important molecule involved in proliferation and pool size of HSPCs in the BM is the hypoxia-induced urokinase-type plasminogen activator receptor (uPAR). Here, we show that the soluble form (sLR11) of LR11 (also called SorLA or SORL1) modulates the uPAR-mediated attachment of HSPCs under hypoxic conditions. Immunohistochemical and mRNA expression analyses revealed that hypoxia increased LR11 expression in hematological c-Kit(+) Lin(-) cells. In U937 cells, hypoxia induced a transient rise in LR11 transcription, production of cellular protein, and release of sLR11. Attachment to stromal cells of c-Kit(+) Lin(-) cells of lr11(-/-) mice was reduced by hypoxia much more than of lr11(+/+) animals. sLR11 induced the adhesion of U937 and c-Kit(+) Lin(-) cells to stromal cells. Cell attachment was increased by sLR11 and reduced in the presence of anti-uPAR antibodies. Furthermore, the fraction of uPAR co-immunoprecipitated with LR11 in membrane extracts of U937 cells was increased by hypoxia. CoCl2, a chemical inducer of HIF-1α, enhanced the levels of LR11 and sLR11 in U937 cells. The decrease in hypoxia-induced attachment of HIF-1α-knockdown cells was largely prevented by exogenously added sLR11. Finally, hypoxia induced HIF-1α binding to a consensus binding site in the LR11 promoter. Thus, we conclude that sLR11 regulates the hypoxia-enhanced adhesion of HSPCs via an uPAR-mediated pathway that stabilizes the hematological pool size by controlling cell attachment to the BM niche.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486467      PMCID: PMC3636875          DOI: 10.1074/jbc.M112.442491

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%).

Authors:  Zoran Ivanovic; Francis Hermitte; Philippe Brunet de la Grange; Bernard Dazey; Francis Belloc; Francis Lacombe; Gérard Vezon; Vincent Praloran
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Roles of Sca-1 in hematopoietic stem/progenitor cell function.

Authors:  Steven B Bradfute; Timothy A Graubert; Margaret A Goodell
Journal:  Exp Hematol       Date:  2005-07       Impact factor: 3.084

3.  CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein.

Authors:  A Suzuki; D P Andrew; J A Gonzalo; M Fukumoto; J Spellberg; M Hashiyama; H Takimoto; N Gerwin; I Webb; G Molineux; R Amakawa; Y Tada; A Wakeham; J Brown; I McNiece; K Ley; E C Butcher; T Suda; J C Gutierrez-Ramos; T W Mak
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

4.  The role of hypoxia in the maintenance of hematopoietic stem cells.

Authors:  M G Cipolleschi; P Dello Sbarba; M Olivotto
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

5.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

6.  Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha.

Authors:  Keita Kirito; Norma Fox; Norio Komatsu; Kenneth Kaushansky
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

7.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

8.  LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.

Authors:  Yanjuan Zhu; Hideaki Bujo; Hiroyuki Yamazaki; Kenji Ohwaki; Meizi Jiang; Satoshi Hirayama; Tatsuro Kanaki; Manabu Shibasaki; Kazuo Takahashi; Wolfgang J Schneider; Yasushi Saito
Journal:  Circ Res       Date:  2004-02-05       Impact factor: 17.367

9.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Authors:  G L Wang; B H Jiang; E A Rue; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme.

Authors:  Partha Krishnamurthy; Douglas D Ross; Takeo Nakanishi; Kim Bailey-Dell; Sheng Zhou; Kelly E Mercer; Balazs Sarkadi; Brian P Sorrentino; John D Schuetz
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

View more
  6 in total

Review 1.  Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease.

Authors:  Olav M Andersen; Ina-Maria Rudolph; Thomas E Willnow
Journal:  Acta Neuropathol       Date:  2016-09-16       Impact factor: 17.088

2.  Highly Efficient Genome Modification of Cultured Primordial Germ Cells with Lentiviral Vectors to Generate Transgenic Songbirds.

Authors:  Ivana Gessara; Falk Dittrich; Moritz Hertel; Staffan Hildebrand; Alexander Pfeifer; Carolina Frankl-Vilches; Mike McGrew; Manfred Gahr
Journal:  Stem Cell Reports       Date:  2021-03-18       Impact factor: 7.765

Review 3.  Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.

Authors:  Daniela Alfano; Paola Franco; Maria Patrizia Stoppelli
Journal:  Front Cell Dev Biol       Date:  2022-04-08

4.  Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Takeharu Kawaguchi; Emi Togasaki; Atsuko Yamazaki; Yasumasa Sugita; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Keigo Nishii; Meizi Jiang; Koutaro Yokote; Hideaki Bujo; Chiaki Nakaseko
Journal:  Exp Mol Med       Date:  2014-04-04       Impact factor: 8.718

5.  Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.

Authors:  Andrew J Whittle; Meizi Jiang; Vivian Peirce; Joana Relat; Sam Virtue; Hiroyuki Ebinuma; Isamu Fukamachi; Takashi Yamaguchi; Mao Takahashi; Takeyoshi Murano; Ichiro Tatsuno; Masahiro Takeuchi; Chiaki Nakaseko; Wenlong Jin; Zhehu Jin; Mark Campbell; Wolfgang J Schneider; Antonio Vidal-Puig; Hideaki Bujo
Journal:  Nat Commun       Date:  2015-11-20       Impact factor: 14.919

6.  Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients.

Authors:  Yu Bum Choi; Mi Jung Lee; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo; Hyung Jong Kim
Journal:  BMC Nephrol       Date:  2020-06-15       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.